The country’s second largest software service provider, Infosys on Tuesday said that it has won a 15-year contract worth £1.2 billion (around Rs 14,000 crore) from the UK’s National Health Service Business Services Authority (NHSBSA) to build and manage a next-generation workforce management platform for the NHS in England and Wales. The project, called the Future NHS Workforce Solution, will replace the existing Electronic Staff Record (ESR) system that currently supports 1.9 million NHS employees and processes more than £55 billion in annual payroll.
The new data-driven platform will integrate artificial intelligence and analytics to manage the entire employee lifecycle, from recruitment and onboarding to career progression, payroll, and retirement. It will also serve as a core digital backbone for the NHS’s 10-year health plan, which focuses on creating a modern, resilient, and future-ready workforce. Infosys will use its AI platform, Infosys Topaz, to power the solution, aimed at improving workforce planning, efficiency, and user experience.
“This engagement combines Infosys’s deep digital transformation expertise and AI capabilities to deliver a system that not only streamlines processes but empowers the NHS to enhance the quality of its invaluable services,” Infosys CEO and managing director Salil Parekh said in a statement. NHSBSA Chief Executive Michael Brodie said the project represents more than a system upgrade, describing it as a step toward empowering healthcare staff with better tools to focus on patient care rather than administrative burdens.
The contract, among the largest UK public sector IT deals in recent years, highlights Infosys’s growing role in delivering mission-critical digital systems for governments worldwide. NHSBSA selected the Bengaluru-headquartered firm after a competitive procurement process that evaluated its track record in large-scale transformation, user-centric design, and operational resilience.
For Infosys, the win comes at a crucial juncture when global IT spending remains cautious amid macroeconomic uncertainty. The deal is expected to boost the company’s large-deal momentum, following $3.8 billion in wins recorded during the April–June period.
In the April–June quarter, Infosys reported a sequential revenue rise of 3.3% to R 42,279 crore, while net profit declined 1.6% to Rs 6,921 crore. The company is scheduled to announce its July–September quarter results on Thursday after market hours. Although Infosys shares initially gained on news of the NHS win, they finally closed 0.21% lower at Rs 1,489.80 on the BSE in line with broader market trends.